David Kuperstein is Director/Team Lead for Pfizer’s US hemophilia portfolio. During his time as a marketer with Pfizer, David has worked in a number of therapeutic areas in addition to rare disease including vaccines, inflammation, and oncology, and in different roles across consumer and HCP marketing. His experience across these teams has included product launch and LOE, and he has launched and managed traditional campaigns, patient ambassador programs, mobile applications, and social media efforts. Prior to working at Pfizer, David was a senior consultant with Capgemini Consulting’s Life Sciences practice, where he advised mid-tier and market-leading pharmaceutical companies on promotional effectiveness, closed-loop and multichannel marketing, organizational design, and portfolio management, and authored several articles. David earned an MBA in Strategy, Marketing, and Corporate Finance at NYU’s Stern School of Business and a BA in Economics from Brandeis University.